Comparative Metabolomic Profiling of Hepatocellular Carcinoma Cells Treated with Sorafenib Monotherapy vs. Sorafenib-Everolimus Combination Therapy

BACKGROUND: Sorafenib-everolimus combination therapy may be more effective than sorafenib monotherapy for hepatocellular carcinoma (HCC). To better understand this effect, we comparatively profiled the metabolite composition of HepG2 cells treated with sorafenib, everolimus, and sorafenib-everolimus...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Med Sci Monit
Päätekijät: Zheng, Jian-feng, Lu, Juan, Wang, Xiao-zhong, Guo, Wu-hua, Zhang, Ji-xiang
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: International Scientific Literature, Inc. 2015
Aiheet:
Clinical Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4479262/
https://ncbi.nlm.nih.gov/pubmed/26092946
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/MSM.894669
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia